A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034)
Part of paid clinical trials in Tempe, Arizona.
- Sponsor
- Merck Sharp & Dohme LLC
- Study ID
- NCT06719544
- Phase
- PHASE1
- Status
- Completed
Conditions
- Healthy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Accepted
Interventions
- lithium carbonate — DRUGOral capsule
- enlicitide — DRUGOral tablet
Study Details
Researchers have designed a new study medicine called enlicitide decanoate (MK-0616) as a new way to lower the amount of low-density lipoprotein cholesterol (LDL-C) in a person's blood. Enlicitide decanoate will be called "enlicitide" from this point forward. Lithium (also called lithium carbonate) is a medicine used in bipolar disorder. Researchers want to learn about lithium when taken at the same time with enlicitide. They want to: * Measure a person's blood to find out if the amount of lithium in the blood is the same when lithium is taken alone or with enlicitide * Learn about the safety of lithium when taken alone or with enlicitide and if people tolerate it
Key Dates
- Start date
- Jan 2, 2025
- Status verified
- Feb 2025
- Primary completion
- Jan 27, 2025
- Completion
- Feb 6, 2025
Study Design
- Enrollment
- 16 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Lithium CarbonateOn Day 1 of Period 1, a single oral dose of lithium carbonate will be administered.
- Experimental: Enlicitide with Lithium CarbonateOn Day 1 of Period 2, a single oral dose of lithium carbonate will be coadministered with a single oral dose of enlicitide.
Primary Outcome Measure
Area Under the Concentration Versus Time Curve From Time Zero to Infinity (AUC0-inf) for Lithium in Plasma [ Time Frame: At designated timepoints (up to approximately 5 days post dose) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Celerion ( Site 0002) | Tempe | Arizona | 85283 | - |
Find similar trials in Tempe, AZ
Related Studies
- A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut DysbiosisRecruiting · Mayo Clinic · Scottsdale, Arizona
- A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's DiseaseRecruiting · Mayo Clinic · Scottsdale, Arizona
- Bone Mineral Density Agreement Study Between EOSedge™ Versus Traditional DXARecruiting · Alphatec Spine, Inc. · Phoenix, Arizona
- Increasing Physical Activity Through Social Support and Stress ResilienceRecruiting · Arizona State University · Phoenix, Arizona